VBIV Insider Trading Activity and SEC Form 4 Filings
VBIV insider trading summary
No open-market insider purchases or sales of VBI Vaccines Inc/BC (VBIV) have been reported on SEC Form 4 in the past 12 months.
Latest VBIV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 10, 2023 | Steven Gillis | Director | Buy | $1.0M (609,090 @ $1.65) |
| Apr 6, 2023 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell | $468K (4,251,563 @ $0.11) |
| Apr 6, 2023 | Joseph Edelman | 10% Owner | Sell | $468K (4,251,563 @ $0.11) |
| Apr 6, 2023 | Perceptive Advisors LLC | 10% Owner | Sell | $468K (4,251,563 @ $0.11) |
| Apr 5, 2023 | Joseph Edelman | 10% Owner | Sell | $238K (1,832,563 @ $0.13) |
| Apr 5, 2023 | Perceptive Advisors LLC | 10% Owner | Sell | $238K (1,832,563 @ $0.13) |
| Apr 5, 2023 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell | $238K (1,832,563 @ $0.13) |
| Apr 4, 2023 | Joseph Edelman | 10% Owner | Sell | $770K (4,810,623 @ $0.16) |
| Apr 4, 2023 | Perceptive Life Sciences Master Fund Ltd | 10% Owner | Sell | $770K (4,810,623 @ $0.16) |
| Apr 4, 2023 | Perceptive Advisors LLC | 10% Owner | Sell | $770K (4,810,623 @ $0.16) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.